Oncogene, 1476-5594

Tidskrift

Fler filtreringsmöjligheter
  1. 2020
  2. The Greatwall kinase safeguards the genome integrity by affecting the kinome activity in mitosis

    Xavier Bisteau, Joann Lee, Vinayaka Srinivas, Joanna H.S. Lee, Joanna Niska-Blakie, Gifford Tan, Shannon Y.X. Yap, Kevin W. Hom, Cheng Kit Wong, Jeongjun Chae, Loo Chien Wang, Jinho Kim, Giulia Rancati, Radoslaw M. Sobota, Chris S.H. Tan & Philipp Kaldis, 2020 sep 25, I : Oncogene.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. Hypoxia-induced release, nuclear translocation, and signaling activity of a DLK1 intracellular fragment in glioma

    Elisa Stellaria Grassi, Vasiliki Pantazopoulou & Alexander Pietras, 2020 mar 24, I : Oncogene.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  4. 2019
  5. Premature activation of Cdk1 leads to mitotic events in S phase and embryonic lethality

    Radoslaw Szmyd, Joanna Niska-Blakie, M Kasim Diril, Patrícia Renck Nunes, Konstantinos Tzelepis, Aurélie Lacroix, Noémi van Hul, Lih-Wen Deng, Joao Matos, Oliver Dreesen, Xavier Bisteau & Philipp Kaldis, 2019 feb, I : Oncogene. 38, 7, s. 998-1018

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. ALK positively regulates MYCN activity through repression of HBP1 expression

    Shana Claeys, Geertrui Denecker, Kaat Durinck, Bieke Decaesteker, Liselot M. Mus, Siebe Loontiens, Suzanne Vanhauwaert, Kristina Althoff, Caroline Wigerup, Daniel Bexell, Emmy Dolman, Kai Oliver Henrich, Lea Wehrmann, Ellen M. Westerhout, Jean Baptiste Demoulin, Candy Kumps, Tom Van Maerken, Genevieve Laureys, Christophe Van Neste, Bram De Wilde & 8 andra, Olivier De Wever, Frank Westermann, Rogier Versteeg, Jan J. Molenaar, Sven Påhlman, Johannes H. Schulte, Katleen De Preter & Frank Speleman, 2019, I : Oncogene. 38, 15, s. 2690-2705

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. GABPA inhibits invasion/metastasis in papillary thyroid carcinoma by regulating DICER1 expression

    Xiaotian Yuan, Ninni Mu, Na Wang, Klas Strååt, Anastasios Sofiadis, Yanxia Guo, Adam Stenman, Kailin Li, Guanghui Cheng, Lu Zhang, Feng Kong, Lars Ekblad, Johan Wennerberg, Inga Lena Nilsson, C. Christofer Juhlin, Catharina Larsson & Dawei Xu, 2019, I : Oncogene. 38, 7, s. 965-979

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. Release of transcriptional repression via ErbB2-induced, SUMO-directed phosphorylation of myeloid zinc finger-1 serine 27 activates lysosome redistribution and invasion

    Ditte Marie Brix, Siri Amanda Tvingsholm, Malene Bredahl Hansen, Knut Bundgaard Clemmensen, Tiina Ohman, Valentina Siino, Matteo Lambrughi, Klaus Hansen, Pietri Puustinen, Irina Gromova, Peter James, Elena Papaleo, Markku Varjosalo, José Moreira, Marja Jäättelä & Tuula Kallunki, 2019, I : Oncogene. 38, 17, s. 3170-3184

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. The role of PIP5K1α/pAKT and targeted inhibition of growth of subtypes of breast cancer using PIP5K1α inhibitor

    Martuza Sarwar, Azharuddin Sajid Syed Khaja, Mohammed Aleskandarany, Richard Karlsson, Maryam Althobiti, Niels Ødum, Nigel P Mongan, Nisthman Dizeyi, Heather Johnson, Andrew R Green, Ian O Ellis, Emad A Rakha & Jenny L Persson, 2019, I : Oncogene. 38, 3, s. 375-389 15 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. 2018
  11. Bruton’s tyrosine kinase potentiates ALK signaling and serves as a potential therapeutic target of neuroblastoma

    Tianfeng Li, Yi Deng, Yu Shi, Ruijun Tian, Yonglong Chen, Lin Zou, Julhash U. Kazi, Lars Rönnstrand, Bo Feng, Sun On Chan, Wai Yee Chan, Jianmin Sun & Hui Zhao, 2018 nov, I : Oncogene. 37, 47, s. 6180-6194

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  12. 2017
  13. MLL-ENL-mediated leukemia initiation at the interface of lymphoid commitment

    A. Ugale, P. Säwén, M. Dudenhöffer-Pfeifer, M. Wahlestedt, G. L. Norddahl & D. Bryder, 2017, I : Oncogene. 36, s. 3207-3212

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. 2016
  15. Aberrant activation of the PI3K/mTOR pathway promotes resistance to sorafenib in AML

    O Lindblad, E Cordero, A Puissant, L. Macaulay, A Ramos, N N Kabir, J Sun, J Vallon-Christersson, K Haraldsson, M T Hemann, Åke Borg, F Levander, K Stegmaier, K Pietras, L Rönnstrand & J U Kazi, 2016 sep 29, I : Oncogene. 35, 39, s. 5119-5131 13 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer

    E Englund, M Bartoschek, B Reitsma, L Jacobsson, A Escudero-Esparza, Akira Orimo, K Leandersson, C Hagerling, A Aspberg, P Storm, M Okroj, H Mulder, K Jirström, K Pietras & A M Blom, 2016, I : Oncogene. 35, 43, s. 5585-5596 12 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. 2015
  18. Deubiquitinating activity of CYLD is impaired by SUMOylation in neuroblastoma cells.

    Tamae Kobayashi, Katarzyna Masoumi & Ramin Massoumi, 2015, I : Oncogene. 34, 17, s. 2251-2260

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. MEN1 tumorigenesis in the pituitary and pancreatic islet requires CDK4 but not Cdk2

    M. P. Gillam, D. Nimbalkar, L. Sun, K. Christov, D. Ray, P. Kaldis, X. Liu & H. Kiyokawa, 2015, I : Oncogene. 34, 7, s. 932-938

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. Targeting of nucleotide-binding proteins by HAMLET-a conserved tumor cell death mechanism.

    Chin Shing Ho, Aftab Nadeem, Anna Rydström, Manoj Puthia & Catharina Svanborg, 2015, I : Oncogene.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  21. TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer.

    S Busch, A Acar, Y Magnusson, P Gregersson, Lisa Rydén & G Landberg, 2015, I : Oncogene. 34, 1, s. 27-38

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. The activation loop tyrosine 823 is essential for the transforming capacity of the c-Kit oncogenic mutant D816V.

    Shruti Agarwal, Julhash U. Kazi, Sofie Mohlin, Sven Påhlman & Lars Rönnstrand, 2015, I : Oncogene. 34, 35, s. 4581-4590

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  23. 2014
  24. The PI3-kinase isoform p110δ is essential for cell transformation induced by the D816V mutant of c-Kit in a lipid-kinase-independent manner.

    Jianmin Sun, Sofie Mohlin, A Lundby, Julhash U. Kazi, U Hellman, Sven Påhlman, J V Olsen & Lars Rönnstrand, 2014, I : Oncogene. 33, 46, s. 5360-5369

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. 2013
  26. Expression of Id proteins is regulated by the Bcl-3 proto-oncogene in prostate cancer.

    Kristofer Ahlqvist, Karunakar Saamarthy, A S Syed Khaja, Anders Bjartell & Ramin Massoumi, 2013, I : Oncogene. 32, 12, s. 1601-1608

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. MiR-155-mediated loss of C/EBP beta shifts the TGF-beta response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer

    J. Johansson, T. Berg, E. Kurzejamska, M-F Pang, V. Tabor, M. Jansson, P. Roswall, Kristian Pietras, M. Sund, P. Religa & J. Fuxe, 2013, I : Oncogene. 32, 50, s. 5614-5624

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  28. 2012
  29. Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma

    E. E. Santo, M. E. Ebus, J. Koster, J. H. Schulte, A. Lakeman, P. van Sluis, J. Vermeulen, David Gisselsson Nord, Ingrid Øra, S. Lindner, P. G. Buckley, R. L. Stallings, J. Vandesompele, A. Eggert, H. N. Caron, R. Versteeg & J. J. Molenaar, 2012, I : Oncogene. 31, 12, s. 1571-1581

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  30. The cocaine- and amphetamine-regulated transcript mediates ligand-independent activation of ER alpha, and is an independent prognostic factor in node-negative breast cancer

    D. J. Brennan, D. P. O'Connor, H. Laursen, S. F. McGee, S. McCarthy, R. Zagozdzon, E. Rexhepaj, A. C. Culhane, F. M. Martin, M. J. Duffy, Göran Landberg, Lisa Rydén, S. M. Hewitt, M. J. Kuhar, R. Bernards, R. C. Millikan, J. P. Crown, Karin Jirström & W. M. Gallagher, 2012, I : Oncogene. 31, 30, s. 3483-3494

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  31. 2011
  32. Conserved features of cancer cells define their sensitivity to HAMLET-induced death; c-Myc and glycolysis.

    Petter Storm, Sonja Aits, M K Puthia, A Urbano, T Northen, S Powers, B Bowen, Y Chao, W Reindl, D Y Lee, N L Sullivan, J Zhang, Maria Trulsson, H Yang, J D Watson & Catharina Svanborg, 2011, I : Oncogene. 30, s. 4765-4779

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  33. GLI1-dependent transcriptional repression of CYLD in basal cell carcinoma

    S. Kuphal, G. Shaw-Hallgren, M. Eberl, S. Karrer, F. Aberger, A. K. Bosserhoff & Ramin Massoumi, 2011, I : Oncogene. 30, 44, s. 4523-4530

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  34. Inactivation of promoter 1B of APC causes partial gene silencing: evidence for a significant role of the promoter in regulation and causative of familial adenomatous polyposis

    A. Rohlin, Y. Engwall, K. Fritzell, K. Goransson, A. Bergsten, Z. Einbeigi, Mef Nilbert, P. Karlsson, J. Bjork & M. Nordling, 2011, I : Oncogene. 30, 50, s. 4977-4989

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  35. 2010
  36. An integrative genomics screen uncovers ncRNA T-UCR functions in neuroblastoma tumours

    P. Mestdagh, Erik Fredlund, F. Pattyn, A. Rihani, T. Van Maerken, J. Vermeulen, C. Kumps, B. Menten, K. De Preter, A. Schramm, J. Schulte, R. Noguera, G. Schleiermacher, I. Janoueix-Lerosey, G. Laureys, R. Powel, D. Nittner, J-C Marine, Markus Ringnér, F. Speleman & 1 andra, J. Vandesompele, 2010, I : Oncogene. 29, 24, s. 3583-3592

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  37. PIM1 kinase is destabilized by ribosomal stress causing inhibition of cell cycle progression

    V. Iadevaia, S. Caldarola, L. Biondini, A. Gismondi, Stefan Karlsson, I. Dianzani & F. Loreni, 2010, I : Oncogene. 29, 40, s. 5490-5499

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  38. 2009
  39. Mammalian cell-cycle regulation: Several cdks, numerous cyclins and diverse compensatory mechanisms

    A. Satyanarayana & P. Kaldis, 2009 aug 20, I : Oncogene. 28, 33, s. 2925-2939

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  40. Hematopoietic stem cell ageing is uncoupled from p16(INK4A)-mediated senescence.

    Joanne Attema, Kees-Jan Pronk, Gudmundur Norddahl, Jens Nygren & David Bryder, 2009, I : Oncogene. 28, s. 2238-2243

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  41. 2008
  42. A novel fusion 5 ' AFF3/3 ' BCL2 originated from a t(2;18)(q11.2;q21.33) translocation in follicular lymphoma

    L. Impera, F. Albano, C. Lo Cunsolo, S. Funes, P. Iuzzolino, F. Laveder, Ioannis Panagopoulos, M. Rocchi & C. T. Storlazzi, 2008, I : Oncogene. 27, 47, s. 6187-6190

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  43. 2007
  44. Cell-specific responses to loss of cyclin-dependent kinases

    C. Berthet & P. Kaldis, 2007 jul 5, I : Oncogene. 26, 31, s. 4469-4477

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  45. Arsenic trioxide-induced neuroblastoma cell death is accompanied by proteolytic activation of nuclear Bax.

    Jenny Karlsson, Alexander Pietras, Siv Beckman, Helen Pettersson, Christer Larsson & Sven Påhlman, 2007, I : Oncogene. 26, 42, s. 6150-6159

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  46. ERalpha-CITED1 co-regulated genes expressed during pubertal mammary gland development: implications for breast cancer prognosis

    J McBryan, Jillian Howlin, P A Kenny, T Shioda & F Martin, 2007, I : Oncogene. 26, 44, s. 6406-6419

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  47. Genomic profiling of malignant melanoma using tiling-resolution arrayCGH.

    Göran B Jönsson, C Dahl, Johan Staaf, Therese Törngren, Pär-Ola Bendahl, Markus Ringnér, P Guldberg & Åke Borg, 2007, I : Oncogene. 26, 32, s. 4738-4748

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  48. IGF-II and IGFBP-2 differentially regulate PTEN in human breast cancer cells

    C. M. Perks, E. G. Vernon, Ann Rosendahl, D. Tonge & J. M. P. Holly, 2007, I : Oncogene. 26, 40, s. 5966-5972

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  49. Tumor progression induced by the loss of E-cadherin independent of beta-catenin/Tcf-mediated Wnt signaling

    M. Herzig, F. Savarese, M. Novatchkova, Henrik Semb & G Christofori, 2007, I : Oncogene. 26, 16, s. 2290-2298

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  50. 2006
  51. A gene fusion network in human neoplasia.

    Mattias Höglund, Attila Frigyesi & Felix Mitelman, 2006, I : Oncogene. 25, 18, s. 2674-2678

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  52. CITED1 homozygous null mice display aberrant pubertal mammary ductal morphogenesis

    Jillian Howlin, J McBryan, S Napoletano, T Lambe, E McArdle, T Shioda & F Martin, 2006, I : Oncogene. 25, 10, s. 1532-1542

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  53. Endogenous production of leukotriene D(4) mediates autocrine survival and proliferation via CysLT(1) receptor signalling in intestinal epithelial cells.

    Sailaja Paruchuri, Maryna Mezhybovska, Maria Juhas & Anita Sjölander, 2006, I : Oncogene. 25, 50, s. 6660-6665

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  54. 2005
  55. A role for cyclin A1 in mediating the autocrine expression of vascular endothelial growth factor in prostate cancer.

    Barbara Wegiel, Anders Bjartell, Jenny Ekberg, Virgil Gadaleanu, Cecilia Brunhoff & Jenny L Persson, 2005, I : Oncogene. 24, 42, s. 6385-6393

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  56. BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter

    Valeriu Cismasiu, Karen Adamo, Jennifer Gecewicz, Javier Duque, Qishan Lin & Dorina Avram, 2005, I : Oncogene. 24, 45, s. 6753-6764

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  57. ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis

    Sofie Svensson Månsson, Karin Jirström, Lisa Rydén, G Roos, S Emdin, M Ostrowski & Göran Landberg, 2005, I : Oncogene. 24, 27, s. 4370-4379

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  58. Microarray analyses reveal strong influence of DNA copy number alterations on the transcriptional patterns in pancreatic cancer: implications for the interpretation of genomic amplifications.

    Markus Heidenblad, David Lindgren, Joris A Veltman, Tord Jonson, Eija H Mahlamäki, Ludmila Gorunova, Ad Geurts van Kessel, Eric F P M Schoenmakers & Mattias Höglund, 2005, I : Oncogene. 24, 10, s. 1794-1801

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  59. The role of Smad signaling in hematopoiesis.

    Jonas Larsson & Stefan Karlsson, 2005, I : Oncogene. 24, 37, s. 5676-5692

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  60. Wnt-5a has tumor suppressor activity in thyroid carcinoma

    N Kremenevskaja, R von Wasielewski, AS Rao, C Schofl, Tommy Andersson & G Brabant, 2005, I : Oncogene. 24, 13, s. 2144-2154

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  61. 2004
  62. Microarray expression profiling in melanoma reveals a BRAF mutation signature

    S Pavey, Peter Johansson, L Packer, J Taylor, M Stark, PM Pollock, GJ Walker, GM Boyle, U Harper, SJ Cozzi, K Hansen, L Yudt, C Schmidt, P Hersey, KAO Ellem, MGE O'Rourke, PG Parsons, P Meltzer, Markus Ringnér & NK Hayward, 2004, I : Oncogene. 23, 23, s. 4060-4067

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  63. Regulation of the cyclin A1 protein is associated with its differential subcellular localization in hematopoietic and leukemic cells.

    Jenny Ekberg, Göran Landberg, Caroline Wigerup, Johan Richter, Debra J Wolgemuth & Jenny L Persson, 2004, I : Oncogene. 23, 56, s. 9082-9089

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  64. Staf50 is a novel p53 target gene conferring reduced clonogenic growth of leukemic U-937 cells.

    Susanna Obad, Hans Brunnström, Johan Vallon-Christersson, Åke Borg, Kristina Drott & Urban Gullberg, 2004, I : Oncogene. 23, 23, s. 4050-4059

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  65. 2003
  66. ID2 expression in neuroblastoma does not correlate to MYCN levels and lacks prognostic value

    J Vandesompele, Anders Edsjö, K De Preter, Håkan Axelson, F Speleman & Sven Påhlman, 2003, I : Oncogene. 22, 3, s. 456-460

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  67. 2002
  68. Co-existence of SYT-SSX1 and SYT-SSX2 fusions in synovial sarcomas

    K Yang, WO Lui, YT Xie, AJ Zhang, B Skytting, Nils Mandahl, C Larsson & O Larsson, 2002, I : Oncogene. 21, 26, s. 4181-4190

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  69. Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancers

    WB Archey, KA McEachern, M Robson, K Offit, SAJ Vaziri, G Casey, Åke Borg & BA Arrick, 2002, I : Oncogene. 21, 46, s. 7034-7041

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  70. SHP-2 is involved in heterodimer specific loss of phosphorylation of Tyr771 in the PDGF-beta receptor

    Simon Ekman, Anders Kallin, Ulla Engström, Carl-Henrik Heldin & Lars Rönnstrand, 2002, I : Oncogene. 21, s. 1870-1875

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  71. The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node

    M Loden, Maria Stighall, HN Nielsen, G Roos, SO Emdin, H Ostlund & Göran Landberg, 2002, I : Oncogene. 21, 30, s. 4680-4690

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  72. 2001
  73. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25

    Marc Ladanyi, Man Yee Lui, Cristina R Antonescu, Amber Krause-Boehm, Alfons Meindl, Pedram Argani, John H Healey, Takafumi Ueda, Hideki Yoshikawa, Aurelia Meloni-Ehrig, Poul H B Sorensen, Fredrik Mertens, Nils Mandahl, Herman van den Berghe, Raf Sciot, Paola Cin & Julia Bridge, 2001, I : Oncogene. 20, 1, s. 48-57

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  74. 1999
  75. Characterization of the chronic myelomonocytic leukemia associated TEL-PDGF beta R fusion protein

    Tobias Sjöblom, A Boureux, Lars Rönnstrand, Carl-Henrik Heldin, Jacques Ghysdael & Arne Östman, 1999, I : Oncogene. 18, 50, s. 7055-7062

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  76. Increased mitogenicity of an alphabeta heterodimeric PDGF receptor complex correlates with lack of RasGAP binding

    Simon Ekman, Eva Rupp Thuresson, Carl-Henrik Heldin & Lars Rönnstrand, 1999, I : Oncogene. 18, 15, s. 2481-2488

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  77. Phosphorylation of Shc by Src family kinases is necessary for stem cell factor receptor/c-kit mediated activation of the Ras/MAP kinase pathway and c-fos induction

    Johan Lennartsson, Peter Blume-Jensen, Monica Hermanson, Emma Pontén, Monica Carlberg & Lars Rönnstrand, 1999, I : Oncogene. 18, 40, s. 5546-5553

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  78. SHP-2 binds to Tyr763 and Tyr1009 in the PDGF beta-receptor and mediates PDGF-induced activation of the Ras/MAP kinase pathway and chemotaxis

    Lars Rönnstrand, Ann-Kristin Arvidsson, Anders Kallin, Charlotte Rorsman, Ulf Hellman, Ulla Engström, Christer Wernstedt & Carl-Henrik Heldin, 1999, I : Oncogene. 18, 25, s. 3696-3702

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  79. 1998
  80. Constitutive expression of the Wilms' tumor gene (WT1) in the leukemic cell line U937 blocks parts of the differentiation program

    Helena Svedberg, Kristina Chylicki, Bo Baldetorp, F J 3rd Rauscher & Urban Gullberg, 1998, I : Oncogene. 16, 7, s. 925-932

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  81. Identification of Tyr-762 in the platelet-derived growth factor alpha-receptor as the binding site for Crk proteins

    Koutaro Yokote, Ulf Hellman, Simon Ekman, Y Saito, Lars Rönnstrand, Carl-Henrik Heldin & Seijiro Mori, 1998, I : Oncogene. 16, 10, s. 1229-1239

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  82. 1996
  83. A novel p53 germline alteration identified in a late onset breast cancer kindred

    X F Sun, O Johannsson, S Håkansson, G Sellberg, B Nordenskjöld, H Olsson & A Borg, 1996 jul 18, I : Oncogene. 13, 2, s. 407-11 5 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  84. 1995
  85. Functional diversity of LIM proteins: amino-terminal activation domains in the oncogenic proteins RBTN1 and RBTN2

    I Sánchez-García, H Axelson & T H Rabbitts, 1995 apr 6, I : Oncogene. 10, 7, s. 1301-6 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  86. 1993
  87. CRK proto-oncogene maps to human chromosome band 17p13

    Thoas Fioretos, N Heisterkamp, J Groffen, S Benjes & C Morris, 1993, I : Oncogene. 8, 10, s. 2853-2855

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  88. 1992
  89. Functional homology between N-myc and c-myc in murine plasmacytomagenesis: plasmacytoma development in N-myc transgenic mice

    Y Wang, H Sugiyama, H Axelson, C K Panda, M Babonits, A Ma, J M Steinberg, F W Alt, G Klein & F Wiener, 1992 jun, I : Oncogene. 7, 6, s. 1241-7 7 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  90. 1991
  91. A new variant 15; 16 translocation in mouse plasmacytoma leads to the juxtaposition of c-myc and immunoglobulin lambda

    H Axelson, C K Panda, S Silva, H Sugiyama, F Wiener, G Klein & J Sumegi, 1991 dec, I : Oncogene. 6, 12, s. 2263-70 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  92. ERBB2 amplification in breast cancer with a high rate of proliferation

    Åke Borg, Bo Baldetorp, Mårten Fernö, Dick Killander, Håkan Olsson & H Sigurdsson, 1991, I : Oncogene. 6, 1, s. 137-143

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  93. 1988
  94. Aberrant class switching juxtaposes c-myc with a middle repetitive element (LINE) and an IgH intron in two spontaneously arising rat immunocytomas

    W S Pear, S F Nelson, H Axelson, G Wahlström, H Bazin, G Klein & J Sümegi, 1988 maj, I : Oncogene. 2, 5, s. 499-507 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift